Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients

Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients

The DecisionDx-Melanoma test provides prognostic information for patients with cutaneous melanoma (CM). Using formalin-fixed paraffin-embedded primary tumor tissue, the RT-PCR-based test classifies patients into a low- (Class 1) or high-risk (Class 2) category for recurrence based on expression of 3...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Robert W. Cook, Brooke Middlebrook, Jeff Wilkinson, Kyle R. Covington, Kristen M. Oelschlager, Federico A. Monzon, John F. Stone
Médium: Artigo
Jazyk:angličtina
Vydáno: 2018
On-line přístup:https://doi.org/10.1186/s13000-018-0690-3
https://diagnosticpathology.biomedcentral.com/track/pdf/10.1186/s13000-018-0690-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Internet

https://doi.org/10.1186/s13000-018-0690-3
https://diagnosticpathology.biomedcentral.com/track/pdf/10.1186/s13000-018-0690-3

Podobné jednotky